| Literature DB >> 31511996 |
Maeva Rodriguez1, Arnaud W Thille1,2, Florence Boissier1,2, Anne Veinstein1, Delphine Chatellier1, René Robert1,2, Sylvain Le Pape1,2, Jean-Pierre Frat1,2, Remi Coudroy3,4.
Abstract
BACKGROUND: High-flow nasal oxygen therapy (HFOT) is a promising first-line therapy for acute respiratory failure. However, its weaning has never been investigated and could lead to unnecessary prolonged intensive-care unit (ICU) stay. The aim of this study is to assess predictors of successful separation from HFOT in critically ill patients. We performed a retrospective monocenter observational study over a 2-year period including all patients treated with HFOT for acute respiratory failure in the ICU. Those who died or were intubated without prior HFOT separation attempt, who were treated with non-invasive ventilation at the time of HFOT separation, or who received HFOT as a preventive treatment during the post-extubation period were excluded.Entities:
Keywords: High-flow nasal oxygen therapy; Intensive-care units; Length of stay; Observational study; Oximetry; Ventilator weaning
Year: 2019 PMID: 31511996 PMCID: PMC6738360 DOI: 10.1186/s13613-019-0578-8
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Fig. 1Flow chart of patients included over the study period
Baseline characteristics of patients who failed under HFOT and who had at least one HFOT separation attempt
| Baseline characteristics | HFOT failure | At least one HFOT separation attempt | |
|---|---|---|---|
| Age, years | 65 ± 12 | 61 ± 15 | 0.03 |
| Gender, female, | 27 (34%) | 61 (32%) | 0.85 |
| Simplified acute physiology score II, points | 53 ± 21 | 37 ± 12 | < 0.001 |
| Sequential organ failure assessment score, points | 8 ± 5 | 5 ± 3 | < 0.001 |
HFOT high-flow nasal oxygen therapy
Characteristics of patients according to the success or failure of the first separation attempt from high-flow nasal oxygen therapy
| Variables | Success | Failure | |
|---|---|---|---|
| Baseline characteristics | |||
| Age, years | 61 ± 15 | 61 ± 14 | 0.93 |
| Gender, female, | 55 (33%) | 6 (27%) | 0.81 |
| Simplified acute physiology score II, points | 36 ± 12 | 40 ± 13 | 0.22 |
| Sequential organ failure assessment score, points | 5 ± 3 | 5 ± 4 | 0.74 |
| Comorbidities, | |||
| Chronic cardiac failure | 32 (19%) | 4 (18%) | > 0.99 |
| Chronic respiratory failure | |||
| Obstructive | 31 (18%) | 5 (23%) | 0.85 |
| Restrictive | 10 (5.9%) | 2 (9.1%) | 0.92 |
| Immunosuppression | 56 (33%) | 8 (36%) | 0.97 |
| Main reason for acute respiratory failure, | |||
| Pneumonia | 79 (47%) | 16 (73%) | 0.04 |
| Cardiogenic pulmonary edema | 28 (17%) | 1 (4.5%) | 0.21 |
| Extrapulmonary sepsis | 26 (15%) | 1 (4.5%) | 0.32 |
| Acute exacerbation of chronic respiratory failure | 9 (5.4%) | 1 (4.5%) | > 0.99 |
| Pulmonary embolism | 7 (4.2%) | 1 (4.5%) | > 0.99 |
| Shock | 4 (2.4%) | 0 (0%) | > 0.99 |
| Neurological failure | 4 (2.4%) | 0 (0%) | > 0.99 |
| Drug abuse | 2 (1.2%) | 0 (0%) | > 0.99 |
| Other diagnoses | 1 (6.0%) | 2 (9.1%) | 0.63 |
| Characteristics before the first separation attempt from HFOT | |||
| Bilateral infiltrates at chest X-ray, | 59 (35%) | 10 (45%) | 0.48 |
| Vasoactive drugs, | 8 (5%) | 0 (0%) | 0.63 |
| Length of treatment with HFOT, hours | 41 (23–72) | 56 (39–80) | 0.26 |
| Last clinical and biological parameters before the first separation attempt from HFOT | |||
| Flow, L/min | 42 ± 8 | 43 ± 8 | 0.54 |
| FiO2 set, % | 39 ± 7 | 48 ± 16 | 0.02 |
| Temperature, °C | 37.3 ± 0.8 | 37.4 ± 0.8 | 0.54 |
| Systolic arterial pressure, mmHg | 125 ± 19 | 127 ± 19 | 0.68 |
| Heart rate, beats/min | 92 ± 19 | 94 ± 20 | 0.60 |
| Respiratory rate, breaths/min | 21 ± 5 | 22 ± 5 | 0.59 |
| Pulse oximetry, % | 96 ± 2 | 96 ± 2 | 0.36 |
| SpO2/FiO2, % | 254 ± 45 | 217 ± 53 | 0.004 |
| ROX index | 12.7 ± 1.2 | 10.2 ± 3.0 | 0.002 |
| PaO2, mmHg | 95 ± 33 | 96 ± 33 | 0.92 |
| PaCO2, mmHg | 35 ± 7 | 36 ± 8 | 0.68 |
| pH | 7.45 ± 0.05 | 7.44 ± 0.05 | 0.72 |
| Serum bicarbonate, mmol/L | 24 ± 5 | 24 ± 5 | 0.99 |
| Last PaO2/FiO2 under HFOT, mmHg | 226 ± 64 | 210 ± 72 | 0.35 |
| Sequential organ failure assessment score, points | 3 ± 2 | 1 ± 2 | 0.27 |
| First clinical parameters under standard oxygen after the separation attempt from HFOT | |||
| Flow, L/min | 4 ± 1 | 5 ± 1 | 0.02 |
| Temperature, °C | 37.4 ± 0.7 | 37.4 ± 0.9 | 0.92 |
| Systolic arterial pressure, mmHg | 125 ± 18 | 131 ± 17 | 0.15 |
| Heart rate, beats/min | 91 ± 18 | 92 ± 16 | 0.75 |
| Respiratory rate, breaths/min | 23 ± 5 | 22 ± 5 | 0.39 |
| Pulse oximetry, % | 96 ± 3 | 95 ± 3 | 0.13 |
| SpO2/FiO2, % | 286 ± 39 | 263 ± 28 | 0.001 |
| ROX index | 13.3 ± 3.9 | 12.7 ± 3.2 | 0.47 |
| Outcomes | |||
| Total length of HFOT treatment, h | 41 (23–72) | 84 (61–118) | < 0.0001 |
| ICU length of stay, days | 5 (4–8) | 10 (7–12) | < 0.0001 |
| Time from HFOT separation success to ICU discharge, days | 2 (1–3) | 2 (2–3) | 0.21 |
HFOT high-flow nasal oxygen therapy, ICU intensive-care unit, FiO fraction of inspired oxygen, PaO partial pressure in oxygen, SpO oxygen saturation, ROX SpO2/FiO2 to respiratory rate
Fig. 2Last physiological parameters recorded at the bedside under high-flow nasal oxygen therapy before the first separation attempt. a Box-plot of FiO2 according to the success or failure of the first separation attempt (p = 0.02). b Box-plot of the ROX index according to the success or failure of the first separation attempt (p = 0.002)
Clinical and biological parameters under high-flow nasal oxygen therapy in the failure group, before separation and after failure
| Last values under HFOT before HFOT separation | First values under HFOT after HFOT resumption | ||
|---|---|---|---|
| Temperature, °C | 37.4 ± 0.8 | 37.4 ± 0.8 | 0.89 |
| Respiratory rate, /min | 22 ± 5 | 21 ± 5 | 0.52 |
| Pulse oximetry, % | 96 ± 2 | 96 ± 3 | 0.89 |
| Systolic arterial pressure, mmHg | 127 ± 19 | 131 ± 17 | 0.32 |
| Heart rate, /min | 94 ± 20 | 97 ± 20 | 0.28 |
| Flow, L/min | 43 ± 8 | 50 ± 5 | 0.001 |
| FiO2, % | 48 ± 16 | 56 ± 15 | 0.12 |
| SpO2/FiO2, % | 217 ± 53 | 183 ± 41 | 0.03 |
| ROX index | 10.2 ± 3.0 | 9.1 ± 3.7 | 0.30 |
| PaO2, mmHg | 96 ± 33 | 84 ± 20 | 0.09 |
| PaCO2, mmHg | 36 ± 8 | 43 ± 20 | 0.18 |
| pH, mmHg | 7.44 ± 0.05 | 7.42 ± 0.10 | 0.52 |
| Serum bicarbonate, mmol/L | 24 ± 5 | 26 ± 5 | 0.08 |
| PaO2/FiO2 under HFOT, mmHg | 210 ± 72 | 148 ± 38 | 0.006 |
HFOT high-flow nasal oxygen therapy, ICU intensive-care unit, FiO fraction of inspired oxygen, PaO partial pressure in oxygen, SpO oxygen saturation, ROX SpO2/FiO2 to respiratory rate